The most deadly of all cancers are driven by mutations in a family of genes known as RAS. In a new article on the website for the National Cancer Institute’s RAS Initiative, Cosimo Commisso, PhD, assistant professor in SBP’s NCI-designated Cancer Center, discusses how the metabolism of cancer cells might be different in different parts of solid tumors.

The RAS Initiative is a collaborative effort to explore innovative approaches for attacking the proteins encoded by mutant forms of RAS genes, which drive 30% of human cancers.